CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 64 filers reported holding CTI BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,526,632 | -76.2% | 601,579 | -83.8% | 1.04% | -31.3% |
| Q4 2022 | $10,637,000 | -8.9% | 3,702,651 | -15.6% | 1.51% | -41.2% |
| Q3 2022 | $11,681,000 | -19.3% | 4,389,546 | -20.0% | 2.57% | +56.3% |
| Q2 2022 | $14,470,000 | -43.6% | 5,489,546 | 0.0% | 1.65% | -72.3% |
| Q1 2022 | $25,636,000 | +745.0% | 5,489,546 | +348.6% | 5.95% | +631.7% |
| Q4 2021 | $3,034,000 | – | 1,223,595 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |